γ-Glutamylcysteine synthetase mediates the c-Myc-dependent response to antineoplastic agents in melanoma cells

Molecular Pharmacology

Volumn 72, Issue 4, 2007, Pages 1015-1023

  Benassi, Barbara ^a   Zupi, Gabriella ^a   Biroccio, Annamaria ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; GLUTAMATE CYSTEINE LIGASE; MYC PROTEIN; REACTIVE OXYGEN METABOLITE; STAUROSPORINE;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG RESPONSE; DRUG SENSITIVITY; ENZYME INHIBITION; ENZYME SUBUNIT; GENE EXPRESSION; GLUTATHIONE METABOLISM; HUMAN; HUMAN CELL; MELANOMA CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; UPREGULATION;

ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL LINE, TUMOR; CISPLATIN; FLUOROURACIL; GLUTAMATE-CYSTEINE LIGASE; GLUTATHIONE; HUMANS; MELANOMA; PROTO-ONCOGENE PROTEINS C-MYC; REACTIVE OXYGEN SPECIES; STAUROSPORINE;

EID: 34748871336     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.107.038687     Document Type: Article

References (38)

1. Adhikary S and Eilers M (2005) Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 6:635-645. 16064138
2. Albihn A, Loven J, Ohlsson J, Osorio LM, and Henriksson M (2006) c-Myc-dependent etoposide-induced apoptosis involves activation of Bax and caspases, and PKC-delta signaling. J Cell Biochem 98:1597-1614. 16572399
3. Arango D, Corner GA, Wadler S, Catalano PJ, and Augenlicht LH (2001) c-myc/p53 interaction determines sensitivity of human colon carcinoma cells to 5-fluorouracil in vitro and in vivo. Cancer Res 61:4910-4915. 11406570
4. Augenlicht LH, Wadler S, Corner G, Richards C, Ryan L, Multani AS, Pathak S, Benson A, Haller D, and Heerdt BG (1997) Low level c-myc amplification in human colonic carcinoma cell lines and tumors: a frequent, p53-independent mutation associated with improved outcome in a randomized multi-institutional trial. Cancer Res 57:1769-1775. 9135021
5. Benassi B, Fanciulli M, Fiorentino F, Porrello A, Chiorino G, Loda M, Zupi G, and Biroccio A (2006) c-Myc phosphorylation is required for cellular response to oxidative stress. Mol Cell 21:509-519. 16483932
6. Biroccio A, Benassi B, Amodei S, Gabellini C, Del Bufalo D, and Zupi G (2001) c-Myc down-regulation increases susceptibility to cisplatin through reactive oxygen species-mediated apoptosis in M14 human melanoma cells. Mol Pharmacol 60:174-182. 11408612
7. Biroccio A, Benassi B, Filomeni G, Amodei S, Marchini S, Chiorino G, Rotilio G, Zupi G, and Ciriolo MR (2002) Glutathione influences c-Myc-induced apoptosis in M14 human melanoma cells. J Biol Chem 277:43763- 43770. 12226097
8. Biroccio A, Benassi B, Fiorentino F, and Zupi G (2004) Glutathione depletion induced by c-Myc downregulation triggers apoptosis on treatment with alkylating agents. Neoplasia 6:195-206. 15153331 Year does not match (PubMed did not provide).
9. Ceballos E, Munoz-Alonso MJ, and Berwanger B (2005) Inhibitory effect of c-Myc on p53-induced apoptosis in leukemia cells. Microarray analysis reveals defective induction of p53 target genes and upregulation of chaperons genes. Oncogene 24:4559-4571. 15856024
10. kip1 levels. Oncogene 20:2814-2825. 11420693 First author name does not match (D'Agnano).
11. Dang CV (1999) c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol 19:1-11. 9858526
12. Das GC, Bacsi A, Shrivastav M, Hazra TK, and Boldogh I (2006) Enhanced γ-glutamylcysteine synthetase activity decreases drug-induced oxidative stress levels and cytotoxicity. Mol Carcinog 45:635-647. 16491484
13. de Alborán IM, Baena E, and Martinez-A C (2004) c-Myc deficient B lymphocytes are resistant to spontaneous and induced cell death. Cell Death Differ 11:61-68. 12970677 First author name does not match (de Alborán).
14. Deneke SM and Fanburg BL (1989) Regulation of cellular glutathione. Am J Physiol 257:L163-L173. 2572174
15. Desbiens KM, Deschesnes RG, Labrie MM, Desfossés Y, Lambert H, Landry J, and Bellmann K (2003) c-Myc potentiates the mitochondrial pathway of apoptosis by acting upstream of apoptosis signal-regulating kinase 1 (Ask1) in the p38 signalling cascade. Biochem J 372:631-641. 12646044
16. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, and Hancock DC (1992) Induction of apoptosis in fibroblasts by c-myc. protein. Cell 69:119-128. 1555236
17. Galloway DC, Blake DG, Shepherd AG, and McLellan LI (1997) Regulation of human γ-glutamylcysteine synthetase: co-ordinate induction of the catalytic and regulatory subunits in HepG2 cells. Biochem J 328:99-104. 9359839
18. Gately DP and Howell SB (1993) Cellular accumulation of the anticancer agent cisplatin: a review. Br J Cancer 67:1171-1176. 8512802
19. Godwin AK, Meister A, O'Dwyer PJ, Huang CS, Hamilton TC, and Anderson ME (1992) High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc Natl Acad Sci U S A 89:3070-3074. 1348364
20. Grassilli E, Ballabeni A, Maellaro E, Del Bello B, and Helin K (2004) Loss of Myc confers resistance to doxorubicin-induced apoptosis by preventing the activation of multiple serine protease- and caspase-mediated pathways. J Biol Chem 279: 21318-21326. 14990581
21. Iida T, Kijima H, Urata Y, Goto S, Ihara Y, Oka M, Kohno S, Scanlon KJ, and Kondo T (2001) Hammerhead ribozyme against γ-glutamylcysteine synthetase sensitizes human colonic cancer cells to cisplatin by down-regulating both the glutathione synthesis and the expression of multidrug resistance proteins. Cancer Gene Ther 8:803-814. 11687904
22. Iida T, Mori E, Mori K, Goto S, Urata Y, Oka M, Kohno S, and Kondo T (1999) Co-expression of γ-glutamylcysteine synthetase sub-units in response to cisplatin and doxorubicin in human cancer cells. Int J Cancer 82:405-411. 10399958
23. Leonetti C, Biroccio A, Candiloro A, Citro G, Fornari C, Mottolese M, Del Bufalo D, and Zupi G (1999) Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin. Clin Cancer Res 5:2588-2595. 10499637
24. Longley DB, Harkin DP, and Johnston PG (2003) 5-Fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 3:330-338. 12724731
25. Meyskens FL Jr, Farmer P, and Fruehauf JP (2001) Redox regulation in human melanocytes and melanoma. Pigment Cell Res 14:148-154. 11434561
26. Moinova HR and Mulcahy RT (1998) An electrophile responsive element (EpRE) regulates β-naphthoflavone induction of the human γ-glutamylcysteine synthetase regulatory subunit gene. Constitutive expression is mediated by an adjacent AP-1 site. J Biol Chem 273:14683-14689. 9614065
27. Mulcahy RT, Bailey HH, and Gipp JJ (1995) Transfection of complementary DNAs for the heavy and light subunits of human γ-glutamylcysteine synthetase results in an elevation of intracellular glutathione and resistance to melphalan. Cancer Res 55:4771-4775. 7585502
28. Mulcahy RT, Wartman MA, Bailey HH, and Gipp JJ (1997) Constitutive and β-naphthoflavone-induced expression of the human γ-glutamylcysteine synthetase heavy subunit gene is regulated by a distal antioxidant response element/TRE sequence. J Biol Chem 272:7445-7454. 9054446
29. Nilsson JA and Cleveland JL (2003) Myc pathways provoking cell suicide and cancer. Oncogene 22:9007-9021. 14663479
30. Park JK, Chung YM, Kang S, Kim JU, Kim YT, Kim HJ, Kim YH, Kim JS, and Yoo YD (2002) c-Myc exerts a protective function through ornithine decarboxylase against cellular insults. Mol Pharmacol 62:1400-1408. 12435808
31. Pelengaris S, Khan M, and Evan G (2002) c-MYC: more than just a matter of life and death. Nat Rev Cancer 2:764-776. 12360279
32. Polsky D and Cordon-Cardo C (2003) Oncogenes in melanoma. Oncogene 22:3087-3091. 12789285
33. Pompella A, De Tata V, Paolicchi A, and Zunino F (2006) Expression of γ-glutamyltransferase in cancer cells and its significance in drug resistance. Biochem Pharmacol 71:231-238. 16303117
34. Seleznev K, Zhao C, Zhang XH, Song K, and Ma ZA (2006) Calcium-independent phospholipase A2 localizes in and protects mitochondria during apoptotic induction by staurosporine. J Biol Chem 281:22275-22288. 16728389
35. Siomek A, Tujakowski J, Gackowski D, Rozalski R, Foksinski M, Dziaman T, Roszkowski K, and Olinski R (2006) Severe oxidatively damaged DNA after cisplatin treatment of cancer patients. Int J Cancer 119:2228- 2230. 16804900
36. Wild AC, Gipp JJ, and Mulcahy T (1998) Overlapping antioxidant response element and PMA response element sequences mediate basal and β-naphthoflavone-induced expression of the human γ-glutamylcysteine synthetase catalytic subunit gene. Biochem J 332:373-381. 9601066
37. Wild AC and Mulcahy T (2000) Regulation of γ-glutamylcysteine synthetase subunit gene expression: insights into transcriptional control of antioxidant defenses. Free Radic Res 32:281-301. 10741850
38. Zeller KI, Jegga AG, Aronow BJ, O'Donnell KA, and Dang CV (2003) An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets. Genome Biol 4:R69. 14519204 First page number name does not match (R69).